OPIOIDS Flashcards
1
Q
Do opioids have anti-inflammatory effect?
A
No
2
Q
What are the problems that can occur with opioids?
A
- Tolerance (There is a decreased level of response despite maintaining the same dose)
- Dependence (if you stop the drug you get a psychological response)
- Side-effects
- Risk of overdose
3
Q
Opioid SEs
A
- Sedation (AVOID DRIVING)
- Nausea and vomiting
- Convulsions
- Respiratory depression
- Constipation
- Urinary retention!!
- Pupil constriction
- Suppression of cough
- CV effects (at high doses)
- Euphoric state
Dry mouth
Euphoria
Sedation
Itch
GI - CONSTIPATION
N+V
Eyes - pupils constriction
Resp depress
4
Q
List the weak opioids
A
- Codeine
- Dihydrocodeine
- Meptazinol
5
Q
Morphine
A
- Given every 4 hours (or every 12 or 24 hours if MR)
- Some brands e.g. MST Continus, Morphgesic SR, Sevredol, MXL, Zomorph,
Oramorph - For oral solution, anything above 13mg/5ml is considered as schedule 2 CD (and anything less is just POM)
6
Q
Morphine - common SE
A
N+V
Hypotension
7
Q
Diamorphine
A
- Causes less nausea and hypotension than morphine
- Because of its solubility, it allows effective doses to be injected in smaller volumes (its good for palliative care)
8
Q
Buprenorphine
A
- Has both opioid agonist and antagonist properties
- Unlike other opioids, its effects are only partially reversed by naltrexone
9
Q
Buprenorphine - duration of action
A
- Much longer duration of action than morphine
- Sublingually, it is active for up to 8 hours
- Can be used as maintenance therapy in the management of opioid dependence (e.g. addicts)
10
Q
What are the counseling points for buprenorphine oral lyophilisates (e.g.
Espranor)?
A
- Placed on the tongue and allowed to dissolve
- Patients should be advised not to swallow for 2 minutes
- They should not consume food or drink for at least 5 minutes after administration
11
Q
Espranor and bioavailability?
A
- Espranor does not have the same bioavailability as other buprenorphine preparations
- So becareful when switching to another preparation
12
Q
What are the cautions for transdermal use of buprenorphine
patches which requires extra monitoring?
A
- Fever
AND - Application site exposed to heat
These two increase the risk of absorption (e.g. therefore side effects)
13
Q
What are the counselling points for patients on
Buprenorphine
patches?
A
- Apply to dry, non-irritated, non-hairy skin on the upper torso/upper arm (depends on which preparation)
- Change patch every 72 hours or 96 hours or 7 days
- Do not put the patch on the same area, and avoid that area for however long the
manufacturer recommends e.g.
7 days or 3 weeks)
14
Q
Fentanyl
A
- The main formulation is the patch which is changed every 72 hours
15
Q
What is the side-effect of IV fentanyl?
A
Muscle rigidity